Reuters: Health News: Biogen's purchase of MS drug ends rocky partnership with Elan

Biogen's purchase of MS drug ends rocky partnership with Elan

BOSTON (Reuters) - Biogen Idec Inc's agreement to buy Elan Corp Plc's interest in the multiple sclerosis drug Tysabri gives Biogen full control of a p...

Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/4lPsY14qO9E/us-biogen-elan-tysabri-idUSBRE9151DV20130206